• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MEK抑制通过YAP在突变的HCT-15细胞中诱导经典WNT信号通路,并通过与TNKS抑制相结合形成癌症预防的FOXO3/FOXM1比率。

MEK Inhibition Induces Canonical WNT Signaling through YAP in Mutated HCT-15 Cells, and a Cancer Preventive FOXO3/FOXM1 Ratio in Combination with TNKS Inhibition.

作者信息

Solberg Nina Therese, Melheim Maria, Strand Martin Frank, Olsen Petter Angell, Krauss Stefan

机构信息

Unit for Cell Signaling, Department of Immunology and Transfusion Medicine, Oslo University Hospital, 0372 Oslo, Norway.

Hybrid Technology Hub-Centre of Excellence, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, PO Box 1112 Blindern, 0317 Oslo, Norway.

出版信息

Cancers (Basel). 2019 Feb 1;11(2):164. doi: 10.3390/cancers11020164.

DOI:10.3390/cancers11020164
PMID:30717152
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6406699/
Abstract

The majority of colorectal cancers are induced by subsequent mutations in and genes leading to aberrant activation of both canonical WNT and RAS signaling. However, due to induction of feedback rescue mechanisms some cancers do not respond well to targeted inhibitor treatments. In this study we show that the and mutant human colorectal cancer cell line HCT-15 induces canonical WNT signaling through YAP in a MEK dependent mechanism. This inductive loop is disrupted with combined tankyrase (TNKS) and MEK inhibition. RNA sequencing analysis suggests that combined TNKS/MEK inhibition induces metabolic stress responses in HCT-15 cells promoting a positive FOXO3/FOXM1 ratio to reduce antioxidative and cryoprotective systems.

摘要

大多数结直肠癌是由 和 基因的后续突变诱导产生的,这些突变会导致经典WNT和RAS信号通路的异常激活。然而,由于反馈拯救机制的诱导,一些癌症对靶向抑制剂治疗反应不佳。在本研究中,我们表明 和 突变的人结直肠癌细胞系HCT-15通过YAP以MEK依赖性机制诱导经典WNT信号通路。这种诱导循环被联合使用端锚聚合酶(TNKS)和MEK抑制所破坏。RNA测序分析表明,联合使用TNKS/MEK抑制可诱导HCT-15细胞中的代谢应激反应,促进FOXO3/FOXM1比值升高,从而降低抗氧化和低温保护系统。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/508c/6406699/37d7662056e0/cancers-11-00164-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/508c/6406699/37d7662056e0/cancers-11-00164-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/508c/6406699/37d7662056e0/cancers-11-00164-g006.jpg

相似文献

1
MEK Inhibition Induces Canonical WNT Signaling through YAP in Mutated HCT-15 Cells, and a Cancer Preventive FOXO3/FOXM1 Ratio in Combination with TNKS Inhibition.MEK抑制通过YAP在突变的HCT-15细胞中诱导经典WNT信号通路,并通过与TNKS抑制相结合形成癌症预防的FOXO3/FOXM1比率。
Cancers (Basel). 2019 Feb 1;11(2):164. doi: 10.3390/cancers11020164.
2
TANKYRASE Inhibition Enhances the Antiproliferative Effect of PI3K and EGFR Inhibition, Mutually Affecting β-CATENIN and AKT Signaling in Colorectal Cancer.TANKYRASE 抑制增强了 PI3K 和 EGFR 抑制对结直肠癌的抗增殖作用,相互影响 β-连环蛋白和 AKT 信号通路。
Mol Cancer Res. 2018 Mar;16(3):543-553. doi: 10.1158/1541-7786.MCR-17-0362. Epub 2017 Dec 8.
3
Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.致癌性KRAS信号通过低密度脂蛋白受体相关蛋白6(LRP6)促进结直肠癌中的Wnt/β-连环蛋白信号通路。
Oncogene. 2015 Sep 17;34(38):4914-27. doi: 10.1038/onc.2014.416. Epub 2014 Dec 15.
4
Distinct Colorectal Cancer-Associated APC Mutations Dictate Response to Tankyrase Inhibition.不同的结直肠癌相关 APC 突变决定了对 Tankyrase 抑制的反应。
Cancer Discov. 2019 Oct;9(10):1358-1371. doi: 10.1158/2159-8290.CD-19-0289. Epub 2019 Jul 23.
5
Inhibiting Tankyrases sensitizes KRAS-mutant cancer cells to MEK inhibitors via FGFR2 feedback signaling.抑制 Tankyrases 通过 FGFR2 反馈信号使 KRAS 突变型癌细胞对 MEK 抑制剂敏感。
Cancer Res. 2014 Jun 15;74(12):3294-305. doi: 10.1158/0008-5472.CAN-14-0138-T. Epub 2014 Apr 18.
6
A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.一种新型 Tankyrase 小分子抑制剂抑制 APC 突变驱动的结直肠肿瘤生长。
Cancer Res. 2013 May 15;73(10):3132-44. doi: 10.1158/0008-5472.CAN-12-4562. Epub 2013 Mar 28.
7
MEK and TAK1 Regulate Apoptosis in Colon Cancer Cells with KRAS-Dependent Activation of Proinflammatory Signaling.MEK和TAK1通过KRAS依赖性激活促炎信号调节结肠癌细胞凋亡。
Mol Cancer Res. 2016 Dec;14(12):1204-1216. doi: 10.1158/1541-7786.MCR-16-0173. Epub 2016 Sep 21.
8
Structure, Dynamics, and Functionality of Tankyrase Inhibitor-Induced Degradasomes. Tankyrase 抑制剂诱导的降解酶体的结构、动态和功能。
Mol Cancer Res. 2015 Nov;13(11):1487-501. doi: 10.1158/1541-7786.MCR-15-0125. Epub 2015 Jun 29.
9
RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells.RAF抑制与MEK抑制在KRAS突变癌细胞中具有协同作用。
Cell Rep. 2014 Sep 11;8(5):1475-83. doi: 10.1016/j.celrep.2014.07.033. Epub 2014 Sep 4.
10
Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS-Mutant Lung Cancer.上皮-间质转化定义了KRAS突变型肺癌中MEK抑制诱导的受体酪氨酸激酶信号的反馈激活。
Cancer Discov. 2016 Jul;6(7):754-69. doi: 10.1158/2159-8290.CD-15-1377. Epub 2016 May 6.

引用本文的文献

1
Hippo/YAP signaling pathway in colorectal cancer: regulatory mechanisms and potential drug exploration.结直肠癌中的Hippo/YAP信号通路:调控机制与潜在药物探索
Front Oncol. 2025 Jun 19;15:1545952. doi: 10.3389/fonc.2025.1545952. eCollection 2025.
2
APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells.APC/PIK3CA 突变和 β-连环蛋白状态可预测患者来源的结直肠癌细胞对端锚聚合酶抑制剂的敏感性。
Br J Cancer. 2024 Jan;130(1):151-162. doi: 10.1038/s41416-023-02484-8. Epub 2023 Nov 15.
3
Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma.

本文引用的文献

1
Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway.Wnt/β-连环蛋白与RAS-ERK信号通路之间的相互作用以及通过靶向Wnt/β-连环蛋白信号通路降解β-连环蛋白和RAS的抗癌策略。
NPJ Precis Oncol. 2018 Feb 20;2(1):5. doi: 10.1038/s41698-018-0049-y. eCollection 2018.
2
Ascl2 activation by YAP1/KLF5 ensures the self-renewability of colon cancer progenitor cells.YAP1/KLF5对Ascl2的激活确保了结肠癌祖细胞的自我更新能力。
Oncotarget. 2017 Nov 27;8(65):109301-109318. doi: 10.18632/oncotarget.22673. eCollection 2017 Dec 12.
3
Hippo-YAP/TAZ 信号通路在肝细胞癌中的复杂作用。
J Cancer Res Clin Oncol. 2023 Nov;149(16):15311-15322. doi: 10.1007/s00432-023-05272-2. Epub 2023 Aug 22.
4
Therapeutic Targeting of Cancer Stem Cells Prevents Resistance of Colorectal Cancer Cells to MEK Inhibition.癌症干细胞的治疗靶向可防止结肠直肠癌细胞对MEK抑制产生耐药性。
ACS Pharmacol Transl Sci. 2022 Aug 25;5(9):724-734. doi: 10.1021/acsptsci.1c00257. eCollection 2022 Sep 9.
5
A Small Molecule Promoting Neural Differentiation Suppresses Cancer Stem Cells in Colorectal Cancer.一种促进神经分化的小分子可抑制结直肠癌中的癌症干细胞。
Biomedicines. 2022 Apr 6;10(4):859. doi: 10.3390/biomedicines10040859.
6
Long-term retinal protection by MEK inhibition in Pax6 haploinsufficiency mice.MEK 抑制在 Pax6 杂合不足小鼠中的长期视网膜保护作用。
Exp Eye Res. 2022 May;218:109012. doi: 10.1016/j.exer.2022.109012. Epub 2022 Mar 1.
7
Single-keratinocyte transcriptomic analyses identify different clonal types and proliferative potential mediated by FOXM1 in human epidermal stem cells.单细胞角质形成细胞转录组分析确定了人类表皮干细胞中由FOXM1介导的不同克隆类型和增殖潜力。
Nat Commun. 2021 May 4;12(1):2505. doi: 10.1038/s41467-021-22779-9.
8
A Small-Molecule Tankyrase Inhibitor Reduces Glioma Stem Cell Proliferation and Sphere Formation.一种小分子端锚聚合酶抑制剂可降低胶质瘤干细胞的增殖和球状体形成。
Cancers (Basel). 2020 Jun 19;12(6):1630. doi: 10.3390/cancers12061630.
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer.
Nrf2 和 YAP 之间的串扰有助于维持膀胱癌的抗氧化潜力和化学耐药性。
Free Radic Biol Med. 2018 Feb 1;115:447-457. doi: 10.1016/j.freeradbiomed.2017.12.005. Epub 2017 Dec 14.
4
TANKYRASE Inhibition Enhances the Antiproliferative Effect of PI3K and EGFR Inhibition, Mutually Affecting β-CATENIN and AKT Signaling in Colorectal Cancer.TANKYRASE 抑制增强了 PI3K 和 EGFR 抑制对结直肠癌的抗增殖作用,相互影响 β-连环蛋白和 AKT 信号通路。
Mol Cancer Res. 2018 Mar;16(3):543-553. doi: 10.1158/1541-7786.MCR-17-0362. Epub 2017 Dec 8.
5
The FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance.FOXO3-FOXM1 轴:癌症药物治疗靶点的关键,也是癌症药物耐药性的调节剂。
Semin Cancer Biol. 2018 Jun;50:77-89. doi: 10.1016/j.semcancer.2017.11.018. Epub 2017 Nov 24.
6
Tankyrase inhibitors suppress hepatocellular carcinoma cell growth via modulating the Hippo cascade.端锚聚合酶抑制剂通过调节Hippo信号通路抑制肝癌细胞生长。
PLoS One. 2017 Sep 6;12(9):e0184068. doi: 10.1371/journal.pone.0184068. eCollection 2017.
7
Roles of Wnt Target Genes in the Journey of Cancer Stem Cells.Wnt靶基因在癌症干细胞进程中的作用
Int J Mol Sci. 2017 Jul 25;18(8):1604. doi: 10.3390/ijms18081604.
8
MEK inhibitors induce Akt activation and drug resistance by suppressing negative feedback ERK-mediated HER2 phosphorylation at Thr701.MEK 抑制剂通过抑制 ERK 介导的 HER2 磷酸化的负反馈 Thr701 位点,诱导 Akt 激活和耐药性。
Mol Oncol. 2017 Sep;11(9):1273-1287. doi: 10.1002/1878-0261.12102. Epub 2017 Jul 19.
9
AHNAK2 is a Novel Prognostic Marker and Oncogenic Protein for Clear Cell Renal Cell Carcinoma.AHNAK2是一种用于透明细胞肾细胞癌的新型预后标志物和致癌蛋白。
Theranostics. 2017 Feb 27;7(5):1100-1113. doi: 10.7150/thno.18198. eCollection 2017.
10
A lignan induces lysosomal dependent degradation of FoxM1 protein to suppress β-catenin nuclear translocation.一种木脂素通过诱导溶酶体依赖性 FoxM1 蛋白降解来抑制β-连环蛋白的核转位。
Sci Rep. 2017 Apr 5;7:45951. doi: 10.1038/srep45951.